This tumor line is derived from a spontaneous glioma arising from Nf1 and Trp53 mutant mice, and is poorly immunogenic, as indicated by its unresponsiveness to anti-PD-1 checkpoint therapy [28]. This evidence concerns the gene NF1 and neoplasm.